Real-World Outcomes of Treating Advanced Breast Cancer Patients With Palbociclib: A Multicenter Retrospective Cohort Study in Japan—The KBCOG-14 Study

BACKGROUND: Clinical studies have shown that palbociclib improves progression-free survival in hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2−) patients with advanced breast cancer (ABC). However, there are insufficient data on its use in a real-world settin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer (Auckl)
Main Authors: Odan, Nina, Kikawa, Yuichiro, Matsumoto, Hajime, Minohata, Junya, Suwa, Hirofumi, Hashimoto, Takashi, Okuno, Toshitaka, Miyashita, Masaru, Saito, Masaru, Yamagami, Kazuhiko, Takao, Shintaro
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780165/
https://ncbi.nlm.nih.gov/pubmed/33447040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1178223420983843
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares